A surface extract of the aerial parts of Salvia chamaedryoides afforded 13 diterpenes (1−13), with seven compounds (1, 3, 4, 7−9, 12) described for the first time. The structures of the new compounds were established using 1D and 2D NMR spectroscopic methods, HRESIMS, and ECD data. The potential hypoglycemic effects of the crude extract, fractions, and pure compounds from S. chamaedryoides were investigated by inhibition of α-glucosidase and α-amylase enzymes. The extract and its fractions showed a moderate dose-dependent inhibition; the pure compounds exhibited differential inhibitory activity against these two enzymes. Molecular modeling studies were also performed to suggest the interaction mode of compound 3 in the α-glucosidase enzyme active site. The antimicrobial activity of the purified compounds was investigated against 26 clinical pathogens. No activity was detected for the Gram-negative species tested nor on Candida albicans and C. glabrata, while variable susceptibilities were observed using Gram-positive staphylococcal and enterococcal species.
Antibacterial and Hypoglycemic Diterpenoids from Salvia chamaedryoides
BISIO, ANGELA;Anna M. Schito;PARRICCHI, ANITA;ALFEI, SILVANA;
2017-01-01
Abstract
A surface extract of the aerial parts of Salvia chamaedryoides afforded 13 diterpenes (1−13), with seven compounds (1, 3, 4, 7−9, 12) described for the first time. The structures of the new compounds were established using 1D and 2D NMR spectroscopic methods, HRESIMS, and ECD data. The potential hypoglycemic effects of the crude extract, fractions, and pure compounds from S. chamaedryoides were investigated by inhibition of α-glucosidase and α-amylase enzymes. The extract and its fractions showed a moderate dose-dependent inhibition; the pure compounds exhibited differential inhibitory activity against these two enzymes. Molecular modeling studies were also performed to suggest the interaction mode of compound 3 in the α-glucosidase enzyme active site. The antimicrobial activity of the purified compounds was investigated against 26 clinical pathogens. No activity was detected for the Gram-negative species tested nor on Candida albicans and C. glabrata, while variable susceptibilities were observed using Gram-positive staphylococcal and enterococcal species.File | Dimensione | Formato | |
---|---|---|---|
Bisio et al_JNP_2017.pdf
solo utenti autorizzati
Descrizione: Articolo principale
Tipologia:
Documento in versione editoriale
Dimensione
620.58 kB
Formato
Adobe PDF
|
620.58 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.